Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Politics
Tobi Thomas Health and inequalities correspondent

Immunotherapy could be used to treat depression, early trial suggests

A hand holds a box of RoActemra tocilizumab medication, with more boxes visible in the background
Participants who received tocilizumab seemed to experience greater improvements over time compared with those given a placebo. Photograph: Pascal Rossignol/Reuters

Immunotherapy could be used to treat depression among patients who have not responded to conventional antidepressants, according to the results of an early clinical trial.

Researchers at the University of Bristol investigated whether tocilizumab, an anti-inflammatory drug commonly used for immune conditions such as rheumatoid arthritis, could improve symptoms of difficult-to-treat depression.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.